
Senators Ed Markey (Democrat – Massachusetts) and Richard Blumenthal (Democrat – Connecticut) have asked new Federal Trade Commission (FTC) Chair Lina Khan to investigate Tesla’s marketing of its advanced driver assistance system, Autopilot. The Senators are particularly concerned with how Tesla has been charging customers thousands of dollars for what it refers to as “Full Self-Driving capability,” despite the fact that buying that package does not make the company’s cars fully autonomous.
“Tesla’s marketing has repeatedly overstated the capabilities of its vehicles, and these statements increasingly pose a threat to motorists and other users of the road,” the senators wrote in a letter published Wednesday, August 18. “Accordingly, we urge you to open an investigation into potentially deceptive and unfair practices in Tesla’s advertising and marketing of its driving automation systems and take appropriate enforcement action to ensure the safety of all drivers on the road.”
The letter comes as the Biden administration has been steadily increasing the scrutiny of tech companies. Much of that focus to date has been through the lens of antitrust policy — especially at the FTC under Khan — but Tesla has drawn some heat as well. Earlier this week, the National Highway Traffic Safety Administration announced an investigation into Autopilot’s tendency to crash into parked emergency vehicles.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas